about
Raf family kinases: old dogs have learned new tricksRewired ERK-JNK signaling pathways in melanomaCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemCurrent Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic WhitesEndoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatmentProgression of cutaneous melanoma: implications for treatmentMelanoma: from mutations to medicineBRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapyMutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cellsUltraviolet radiation and melanoma: a systematic review and analysis of reported sequence variantsRoutine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trialsIntra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaEnvironmental effects of ozone depletion and its interactions with climate change: progress report, 2004.The effects on human health from stratospheric ozone depletion and its interactions with climate change.Improving melanoma classification by integrating genetic and morphologic featuresBeyond histology: translating tumor genotypes into clinically effective targeted therapies.Lack of somatic alterations of MC1R in primary melanomaPrognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.Melanoma epidemiology, biology and prognosis.Germline variation controls the architecture of somatic alterations in tumorsMC1R variants increase risk of melanomas harboring BRAF mutations.Ipilimumab for patients with advanced mucosal melanoma.Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanomaMicrorna profiling analysis of differences between the melanoma of young adults and older adults.Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapyPediatric low-grade gliomas: how modern biology reshapes the clinical field.GAB2 amplifications refine molecular classification of melanoma.Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell linesCorrelation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review.Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.The cancer epidemiology of radiation.The anatomic distribution of melanoma and relationships with childhood nevus distribution in ColoradoAssociation between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysisSuperficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.Driver mutations in melanoma: lessons learned from bench-to-bedside studiesPrimary mucosal melanomas: a comprehensive review.Genetic analysis of the GRM1 gene in human melanoma susceptibility.
P2860
Q24316181-B9212619-EA71-42E6-B53C-24F10375F0D2Q24683737-A37960AB-4D47-4ED9-B91E-6FBD7F9C51C7Q26748510-2168E034-F2E8-4212-A7A3-A3FA797250C6Q26752438-705F31AF-C5CC-4EF6-A190-E13DB139C8BAQ26776032-70BACD93-3967-42D6-B9F9-F3E0CDB194C8Q27001734-09A8A1B3-4671-40D4-9190-982A837AF270Q27024061-80232D3C-E809-41ED-9E5C-F3155CB7BA22Q27852927-BB21D9B8-FEF4-48CF-96B1-D11162C9F3A6Q28259285-3F095D68-9DC1-4E02-AD14-AFAF0D209580Q28287782-4A37E9C0-CB5B-4F68-BB8E-62400084DA7CQ28730438-08FDA14E-195C-445C-8A0C-027B431B58FAQ28740547-3710B075-A128-48BE-B4AF-DFBE65182E83Q30985365-ECB9E155-B8F0-40FF-8F39-39F02CCCB625Q31104682-06164718-89D1-4864-81BE-6AA02B89554FQ33340639-96898545-29E7-40E6-8EFA-50381F348B09Q33560928-1910D12B-944A-481E-A5BB-2C0A53BE8AC7Q33672304-A24208F5-D580-4FB4-A411-8721463D35F5Q33682137-E94001DB-3AE9-46D9-8270-2227A5A8BE11Q33698718-A489ACEA-C43D-4E33-A83F-9D2A6521555FQ33707388-D01A7A79-13F2-41B1-80C4-0B73FD110A18Q33715143-AF8132A6-DE9A-498E-971F-835353224438Q33777469-78E0891E-C190-4A98-B443-601A0E58C852Q33790743-741691C5-FF4E-46DD-ADFD-CA1396F58D8AQ33793054-242A7F87-F9D2-42C4-B0BC-60965EA643BDQ33822934-1A440AA2-ABD9-49CC-92EE-6C3E06922507Q33824552-53D22580-4D66-4E2C-89BC-41606E8A203EQ33847771-BAFBA999-26B7-4605-8838-F0C51525D0C0Q33883923-5B614058-5966-4507-86A0-4DBA72D26D28Q33913913-A72D3C6A-8CF2-4A1D-AF7E-7E7382E62112Q33918101-194AC187-A04F-4E2F-93B7-CF30455B87ACQ34241145-7A90AB73-CD35-4524-9745-0AFE376B7FF6Q34293070-A297648A-4FCF-4D39-BF99-9E9F596778B3Q34342493-BAED5723-0D88-48AE-B3EF-9480683B7BDAQ34371994-B779B6AC-9C12-4B47-B08D-F44A960C1D68Q34454042-814D4D42-4C43-40F7-B3AB-564E2BBA6023Q34561099-A96E7A54-1043-43C1-9B11-EA1A242972FDQ34633885-F6B2E8E5-DE40-4BAB-8EFF-714ADAE3184FQ34639532-82C979E1-B8EB-49EC-A381-EC7028458FB6Q34644082-5153D1D8-9D78-40AB-AE7C-ED593A27C91FQ34645746-E14F9239-FB38-4ECE-BC2A-72FA17197012
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Determinants of BRAF mutations in primary melanomas
@ast
Determinants of BRAF mutations in primary melanomas
@en
Determinants of BRAF mutations in primary melanomas
@nl
type
label
Determinants of BRAF mutations in primary melanomas
@ast
Determinants of BRAF mutations in primary melanomas
@en
Determinants of BRAF mutations in primary melanomas
@nl
prefLabel
Determinants of BRAF mutations in primary melanomas
@ast
Determinants of BRAF mutations in primary melanomas
@en
Determinants of BRAF mutations in primary melanomas
@nl
P2093
P3181
P356
P1476
Determinants of BRAF mutations in primary melanomas
@en
P2093
Ajay N Jain
Boris C Bastian
Dan Pinkel
Donna G Albertson
Hetal Patel
Jane Fridlyand
Janet L Maldonado
Klaus Busam
Tomomichi Ono
Toshiro Kageshita
P304
P3181
P356
10.1093/JNCI/DJG123
P407
P577
2003-12-17T00:00:00Z